chr1-157515636-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_031281.3(FCRL5):c.*39C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000353 in 1,614,172 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00022 ( 1 hom., cov: 33)
Exomes 𝑓: 0.000016 ( 0 hom. )
Consequence
FCRL5
NM_031281.3 3_prime_UTR
NM_031281.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.249
Genes affected
FCRL5 (HGNC:18508): (Fc receptor like 5) This gene encodes a member of the immunoglobulin receptor superfamily and the Fc-receptor like family. This gene and several other Fc receptor-like gene members are clustered on the long arm of chromosome 1. The encoded protein is a single-pass type I membrane protein and contains 8 immunoglobulin-like C2-type domains. This gene is implicated in B cell development and lymphomagenesis. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Sep 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FCRL5 | NM_031281.3 | c.*39C>G | 3_prime_UTR_variant | 17/17 | ENST00000361835.8 | NP_112571.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FCRL5 | ENST00000361835.8 | c.*39C>G | 3_prime_UTR_variant | 17/17 | 1 | NM_031281.3 | ENSP00000354691 | P1 | ||
FCRL5 | ENST00000461387.5 | n.2250C>G | non_coding_transcript_exon_variant | 7/7 | 2 | |||||
FCRL5 | ENST00000462218.1 | n.361C>G | non_coding_transcript_exon_variant | 2/2 | 2 | |||||
FCRL5 | ENST00000497286.5 | n.2066C>G | non_coding_transcript_exon_variant | 9/9 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152274Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
28
AN:
152274
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251262Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135808
GnomAD3 exomes
AF:
AC:
10
AN:
251262
Hom.:
AF XY:
AC XY:
4
AN XY:
135808
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000157 AC: 23AN: 1461780Hom.: 0 Cov.: 30 AF XY: 0.00000825 AC XY: 6AN XY: 727176
GnomAD4 exome
AF:
AC:
23
AN:
1461780
Hom.:
Cov.:
30
AF XY:
AC XY:
6
AN XY:
727176
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000223 AC: 34AN: 152392Hom.: 1 Cov.: 33 AF XY: 0.000335 AC XY: 25AN XY: 74524
GnomAD4 genome
AF:
AC:
34
AN:
152392
Hom.:
Cov.:
33
AF XY:
AC XY:
25
AN XY:
74524
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 08, 2024 | The c.2963C>G (p.T988S) alteration is located in exon 17 (coding exon 17) of the FCRL5 gene. This alteration results from a C to G substitution at nucleotide position 2963, causing the threonine (T) at amino acid position 988 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at